Mission, Vision & Strategy


We are committed to bring hope and relief to patients and their families by developing innovative groundbreaking drugs within Alzheimer’s disease, pain and other devastating disorders.


Our vision is to become a leading neuroscience research and development company providing substantial value to patients and society.


AlzeCure Pharma’s strategy is to develop a broad portfolio of symptomatic, disease-modifying and preventive drugs for Alzheimer’s, pain and other severe illnesses through work based on the following four guidelines:

  • The right patient: Focusing on genetically, clinically and pathologically defined diseases to increase the ability of clinical effect
  • The right mechanism: The treatment acts on genetically associated signaling pathways in Alzheimer’s disease and other indications.
  • The right clinical testing: The clinical studies are based on validated biomarkers and preclinical methods with good translationto humans.
  • The right treatment: Small-molecule drugs that penetrate the blood brain barrier (BBB) and which are designed for safe, efficacious long-term treatment.